Download Free Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Bullous Keratopathy Market: By Type, By Therapy, By Treatment, By End User and Region Forecast 2019-2030
Bullous Keratopathy Market: By Type, By Therapy, By Treatment, By End User and Region Forecast 2019-2030
Bullous Keratopathy Market size was valued at US$ 482 million in 2023 and is poised to grow at a CAGR of 7.2% from 2024-2030. Bullous Keratopathy, also known as pseudophakic bullous keratopathy, is a pathological condition in which small vesicles, or bullae are formed in the cornea due to endothelial dysfunction, resulting in swelling due to the excessive fluid and blisters on the cornea causing blurring of vision, caused by damage or inflammation due to eye surgery, trauma, and glaucoma. Based on the treatment type, amniotic membrane graft is anticipated to dominate the market share over the forecast period. Rising cases of cataract surgeries and the use of advanced technologies in corneal transplant and implant surgeries will act as the drivers for market growth. However, increased risk factors of the surgery with an increase in the risk of surgery failure will have a negative impact on the market. Favorable reimbursement policies and the need for research and development of new treatment methods are opportunities for the expansion of the market.
Study Period
2024-2030Base Year
2023CAGR
7.2%Largest Market
North AmericaFastest Growing Market
North America
Several academic institutions and pharmaceutical companies are currently conducting clinical trials for the treatment of various symptoms of bullous keratopathy. For instance, Corneat Vision, conducted clinical trials for their CorNeat Kpro (artificial cornea), which is likely to be commercialized in 2024. Additionally, Emmecell’s EO2002, a magnetic cell-based therapy, providing easier access to treatment before the disease becomes disabling and painful, is being evaluated in phase-I for surgery involving full-thickness corneal transplantation or endothelial keratoplasty. Thus, rising complications from cataract surgeries, glaucoma surgeries and the growing prevalence of eye disorders will lead to the growth of the market within the forecast period.
The Bullous Keratopathy market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. As per the World Health Organization, globally, approximately 2.2 billion people had near or distant vision impairment and 4.2 million people had corneal opacities in 2020 According to an article published by Progress in Retinal and Eye Research in 2020, the late-onset form of Fuch’s endothelial dystrophy affected approximately 4% of people above 40 years of age in the USA. As per the National Eye Institute, an estimated 30,000 Americans undergo corneal transplants to replace injured and diseased corneas every year. The North America market is expected to dominate the market over the forecast period, majorly because of the highly developed healthcare systems in the United States and Canada, as well as the strong presence of major market players, and the increasing research and development activities in the region. Also, in the European market the increasing research and development investments and practices focused on developing advanced corneal implants will create favorable expansion of the market.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market Size in 2023 |
US$ 482 million |
|
Market CAGR |
7.2% |
|
By Type |
|
|
By Therapy |
|
|
By Treatment |
|
|
By End User |
|
|
By Region |
|
Download Free Sample Report
The bullous keratopathy market size was valued at US$ 482 million in 2023 at a CAGR of 7.2% from 2024-2030
Favorable reimbursement policies and the need for research and development of new treatment methods are the key opportunities in the market.
Rising cases of cataract surgeries and the use of advanced technologies in corneal transplant and implant surgeries are the growth drivers in the market.
Pfizer Inc, Roche Ltd., Regeneron Pharmaceuticals, Bayer AG, Cellusion, CRSTEurope, Barraquer Eye Hospital, Planchard Eye & Laser Center, and Medscape are a few companies operating in the market.
| 1. Executive Summary |
| 2. Global Bullous Keratopathy Market Introduction |
| 2.1.Global Bullous Keratopathy Market - Taxonomy |
| 2.2.Global Bullous Keratopathy Market - Definitions |
| 2.2.1.Type |
| 2.2.2.Therapy |
| 2.2.3.Treatment |
| 2.2.4.End User |
| 2.2.5.Region |
| 3. Global Bullous Keratopathy Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4. Global Bullous Keratopathy Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Bullous Keratopathy Market By Type , 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. Topical Hypertonic Agents |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Medications to Lower Intraocular Pressure |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Others |
| 5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 6. Global Bullous Keratopathy Market By Therapy, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. Emmecell |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Cellulsion |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 7. Global Bullous Keratopathy Market By Treatment, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. Lubricants |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Steroids |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Hyperosmotic Agents |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Anti-glaucoma Drugs |
| 7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Antibiotics |
| 7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 7.6. Amniotic Membrane Graft |
| 7.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.6.3. Market Opportunity Analysis |
| 7.7. Annular Keratotomy |
| 7.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.7.3. Market Opportunity Analysis |
| 7.8. Anterior Stromal Puncture |
| 7.8.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.8.3. Market Opportunity Analysis |
| 8. Global Bullous Keratopathy Market By End User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. Hospitals |
| 8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Clinics |
| 8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Surgical Centers |
| 8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Others |
| 8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 9. Global Bullous Keratopathy Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 9.1. North America |
| 9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. Europe |
| 9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. Asia Pacific (APAC) |
| 9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 9.4. Middle East and Africa (MEA) |
| 9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.4.3. Market Opportunity Analysis |
| 9.5. Latin America |
| 9.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.5.3. Market Opportunity Analysis |
| 10. North America Bullous Keratopathy Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 10.1. Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Topical Hypertonic Agents |
| 10.1.2.Medications to Lower Intraocular Pressure |
| 10.1.3.Others |
| 10.2. Therapy Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Emmecell |
| 10.2.2.Cellulsion |
| 10.3. Treatment Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Lubricants |
| 10.3.2.Steroids |
| 10.3.3.Hyperosmotic Agents |
| 10.3.4.Anti-glaucoma Drugs |
| 10.3.5.Antibiotics |
| 10.3.6.Amniotic Membrane Graft |
| 10.3.7.Annular Keratotomy |
| 10.3.8.Anterior Stromal Puncture |
| 10.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Hospitals |
| 10.4.2.Clinics |
| 10.4.3.Surgical Centers |
| 10.4.4.Others |
| 10.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.5.1.United States of America (USA) |
| 10.5.2.Canada |
| 11. Europe Bullous Keratopathy Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 11.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Topical Hypertonic Agents |
| 11.1.2.Medications to Lower Intraocular Pressure |
| 11.1.3.Others |
| 11.2. Therapy Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Emmecell |
| 11.2.2.Cellulsion |
| 11.3. Treatment Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Lubricants |
| 11.3.2.Steroids |
| 11.3.3.Hyperosmotic Agents |
| 11.3.4.Anti-glaucoma Drugs |
| 11.3.5.Antibiotics |
| 11.3.6.Amniotic Membrane Graft |
| 11.3.7.Annular Keratotomy |
| 11.3.8.Anterior Stromal Puncture |
| 11.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.Hospitals |
| 11.4.2.Clinics |
| 11.4.3.Surgical Centers |
| 11.4.4.Others |
| 11.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.5.1.Germany |
| 11.5.2.France |
| 11.5.3.Italy |
| 11.5.4.United Kingdom (UK) |
| 11.5.5.Spain |
| 11.5.6.Rest of EU |
| 12. Asia Pacific (APAC) Bullous Keratopathy Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 12.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Topical Hypertonic Agents |
| 12.1.2.Medications to Lower Intraocular Pressure |
| 12.1.3.Others |
| 12.2. Therapy Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Emmecell |
| 12.2.2.Cellulsion |
| 12.3. Treatment Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Lubricants |
| 12.3.2.Steroids |
| 12.3.3.Hyperosmotic Agents |
| 12.3.4.Anti-glaucoma Drugs |
| 12.3.5.Antibiotics |
| 12.3.6.Amniotic Membrane Graft |
| 12.3.7.Annular Keratotomy |
| 12.3.8.Anterior Stromal Puncture |
| 12.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.Hospitals |
| 12.4.2.Clinics |
| 12.4.3.Surgical Centers |
| 12.4.4.Others |
| 12.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.5.1.China |
| 12.5.2.India |
| 12.5.3.Australia and New Zealand (ANZ) |
| 12.5.4.Japan |
| 12.5.5.Rest of APAC |
| 13. Middle East and Africa (MEA) Bullous Keratopathy Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 13.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Topical Hypertonic Agents |
| 13.1.2.Medications to Lower Intraocular Pressure |
| 13.1.3.Others |
| 13.2. Therapy Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Emmecell |
| 13.2.2.Cellulsion |
| 13.3. Treatment Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Lubricants |
| 13.3.2.Steroids |
| 13.3.3.Hyperosmotic Agents |
| 13.3.4.Anti-glaucoma Drugs |
| 13.3.5.Antibiotics |
| 13.3.6.Amniotic Membrane Graft |
| 13.3.7.Annular Keratotomy |
| 13.3.8.Anterior Stromal Puncture |
| 13.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Hospitals |
| 13.4.2.Clinics |
| 13.4.3.Surgical Centers |
| 13.4.4.Others |
| 13.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.5.1.GCC Countries |
| 13.5.2.South Africa |
| 13.5.3.Rest of MEA |
| 14.Latin America Bullous Keratopathy Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 14.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.1.1.Topical Hypertonic Agents |
| 14.1.2.Medications to Lower Intraocular Pressure |
| 14.1.3.Others |
| 14.2. Therapy Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.2.1.Emmecell |
| 14.2.2.Cellulsion |
| 14.3. Treatment Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.3.1.Lubricants |
| 14.3.2.Steroids |
| 14.3.3.Hyperosmotic Agents |
| 14.3.4.Anti-glaucoma Drugs |
| 14.3.5.Antibiotics |
| 14.3.6.Amniotic Membrane Graft |
| 14.3.7.Annular Keratotomy |
| 14.3.8.Anterior Stromal Puncture |
| 14.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.4.1.Hospitals |
| 14.4.2.Clinics |
| 14.4.3.Surgical Centers |
| 14.4.4.Others |
| 14.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.5.1.Brazil |
| 14.5.2.Mexico |
| 14.5.3.Rest of LA |
| 15. Competition Landscape |
| 15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 15.2.1.Pfizer Inc |
| 15.2.2.Roche Ltd. |
| 15.2.3.Regeneron Pharmaceuticals |
| 15.2.4.Bayer AG |
| 15.2.5.Cellusion |
| 15.2.6.CRSTEurope |
| 15.2.7.Barraquer Eye Hospital |
| 15.2.8.Planchard Eye & Laser Center |
| 15.2.9.Medscape |
| 16. Research Methodology |
| 17. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.